Estradiol Completed Phase 3 Trials for Myocardial Ischemia / Coronary Heart Disease (CHD) / Myocardial Infarction / Cardiovascular Disease (CVD) / Heart Diseases Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000482Coronary Drug Project
NCT03097120The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.